Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Constant Innovation - Exploring the world of new ideas, creativity and innovation. It started as a fun project during my Fellowship in Silicon Valley, and now continues with reflections, interviews and talks.

Constant Innovation

במלאת חמישים שנה לצאת "2001: אודיסאה בחלל", 11 חוקרים וחוקרות בחנו את היצירה מזווית המומחיות שלהם. עם גיל מרקוביץ ודוקטור יוחאי עתריה

2018 אודיסאה בחלל 2018 a Space Odyssey Podcast

Paediatric Surgeon interested in education & innovation. We have created a series of evidence-based Podcasts aimed at higher Paediatric Surgical Trainees in the UK and worldwide. The discussion is evidence-based with all references provided in the comments section of each podcast. We hope you enjoy listening and learning!

Paediatric Surgeon interested in education &amp; innovation. We have created a series of evidence-based Podcasts aimed at higher Paediatric Surgical Trainees in the UK and worldwide. The discussion is evidence-based with all references provided in the comments section of each podcast. We hope you enjoy listening and learning!

Evidence Based Podcasts in Paediatric Surgery

Buscamos contar historias en distintos lugares del mundo con el fútbol como protagonista y reflexionar sobre cómo eso nos ayuda a entender a las diferentes sociedades que hay. Por Fede Lamas y Nahuel Lanzón. Web: www.alterfutbol.com - Twitter/Instagram: @alterfutbol.

AlterFútbol

Podcast sobre filosofia, cultura e valores morais, com Lucas Azambuja e Rafael Mello Madalozzo.

Ordem Natural

UTS 4 Climate brings together leading thinkers from politics, economics, science and journalism to continue the conversation on climate.

This podcast features conversations conducted in 2020 by the Honourable Bob Carr, Industry Professor of Climate and Business at the University of Technology Sydney. 

This series creates a space to explore climate change from all angles and find practical answers to what we can do to address the climate crisis and secure our futures. 

This podcast was made by Impact Studios at UTS in collaboration with the Institute for Sustainable Futures.

UTS 4 Climate brings together leading thinkers from politics, economics, science and journalism to continue the conversation on climate. This podcast features conversations conducted in 2020 by the Honourable Bob Carr, Industry Professor of Climate and Business at the University of Technology Sydney. This series creates a space to explore climate change from all angles and find practical answers to what we can do to address the climate crisis and secure our futures. This podcast was made by Impact Studios at UTS in collaboration with the Institute for Sustainable Futures.

UTS 4 Climate

Есть тема!

Der neue Podcast „Medizin trifft Zahnmedizin“ ist eine Gemeinschaftsproduktion der Unternehmen MedTriX und intHERcon und verbindet Wissen aus der Human- und Zahn-Medizin. Das Ziel ist es, den interdisziplinären Blick zu stärken, neue Erkenntnisse zu diskutieren und mehr Aufmerksamkeit für wichtige interprofessionelle Zusammenhänge zu schaffen.

Medizin trifft Zahnmedizin

Naturellement vôtre, le podcast des histoires naturelles et de celles et ceux qui les écrivent
Dans cette émission, Bill François vous emmène à la découverte des aventures qui relient notre espèce, les humains, à toutes les autres: plantes et animaux ...
A chaque épisode, une curieuse histoire naturelle, et la rencontre d'une personne qui a lié son destin à celui d'autres espèces.  Artistes, scientifiques, passionnés en tous genres, des traditions les plus anciennes aux découvertes les plus récentes… Nous vous emmenons voyager dans la diversité de la nature.
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

Naturellement vôtre, le podcast des histoires naturelles et de celles et ceux qui les écrivent Dans cette émission, Bill François vous emmène à la découverte des aventures qui relient notre espèce, les humains, à toutes les autres: plantes et animaux ... A chaque épisode, une curieuse histoire naturelle, et la rencontre d'une personne qui a lié son destin à celui d'autres espèces. Artistes, scientifiques, passionnés en tous genres, des traditions les plus anciennes aux découvertes les plus récentes… Nous vous emmenons voyager dans la diversité de la nature. Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

Naturellement vôtre, le podcast des histoires naturelles et de celles et ceux qui les écrivent
Dans cette émission, Bill François vous emmène à la découverte des aventures qui relient notre espèce, les humains, à toutes les autres: plantes et animaux ...
A chaque épisode, une curieuse histoire naturelle, et la rencontre d'une personne qui a lié son destin à celui d'autres espèces.&nbsp; Artistes, scientifiques, passionnés en tous genres, des traditions les plus anciennes aux découvertes les plus récentes… Nous vous emmenons voyager dans la diversité de la nature.
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

NATURELLEMENT VOTRE

Bonjour à toutes et à tous, vous écoutez Rouge Soleil, une émission, un univers, un espace, qui va parler de la boisson la plus consommée au monde après l'eau :&nbsp;Le&nbsp;Café. L'idée à travers ce podcast est d'aborder sous tous les angles la plante qui permet d'obtenir cette boisson caféinée. Au-delà d'échanger sur la torréfaction, les extractions et autres points techniques, c'est également l'idée de s'attarder sur un mode de vie.&nbsp;Comme dit l'adage :&nbsp;dit moi ce que tu manges, je te dirai qui tu es.Et bien, c'est une posture identique que nous allons infiltrer dans le système rouge soleil.&nbsp;Oui, nous pensons qu'il y a mille et une chose à dire, à expliquer, à comprendre, à savoir, et à faire sur cette si petite chose qui généralement arrive en fin de repas :&nbsp;le café. Si vous êtes un simple amateur, barista en herbe, torréfacteur confirmé ou sincèrement curieux, rouge soleil va essayer de s'attaquer aux préjugés, aux a&nbsp;priori&nbsp;que la boisson que l'on nomme l'or noir porte avec elle. Si nous avons autant envie de parler et de défendre sa complexité, c'est que nous avons une relation passionnelle avec le café, pour ses teintes, ses nuances, ses arômes, ses odeurs, et sa capacité à ne pas dire la même chose suivant le langage qu'on utilise avec lui. Une chose est sur c'est que l'un des premiers souvenirs d'un café exceptionnel que nous avons pu boire est attaché à l'un de nos sens.&nbsp;Comme un coup de foudre.Ce n'était ni par l'odorat, ni par le goût, mais bien par le regard porté sur lui.&nbsp;Lui qui oscillait entre une aube écarlate et une aurore incandescente :&nbsp;une apparence Rouge Soleil.&nbsp; Bonne écoute.<hr> Hébergé par Acast. Visitez <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> pour plus d'informations.

Bonjour à toutes et à tous, vous écoutez Rouge Soleil, une émission, un univers, un espace, qui va parler de la boisson la plus consommée au monde après l'eau : Le Café. L'idée à travers ce podcast est d'aborder sous tous les angles la plante qui permet d'obtenir cette boisson caféinée. Au-delà d'échanger sur la torréfaction, les extractions et autres points techniques, c'est également l'idée de s'attarder sur un mode de vie. Comme dit l'adage : dit moi ce que tu manges, je te dirai qui tu es. Et bien, c'est une posture identique que nous allons infiltrer dans le système rouge soleil. Oui, nous pensons qu'il y a mille et une chose à dire, à expliquer, à comprendre, à savoir, et à faire sur cette si petite chose qui généralement arrive en fin de repas : le café. Si vous êtes un simple amateur, barista en herbe, torréfacteur confirmé ou sincèrement curieux, rouge soleil va essayer de s'attaquer aux préjugés, aux a priori que la boisson que l'on nomme l'or noir porte avec elle. Si nous avons autant envie de parler et de défendre sa complexité, c'est que nous avons une relation passionnelle avec le café, pour ses teintes, ses nuances, ses arômes, ses odeurs, et sa capacité à ne pas dire la même chose suivant le langage qu'on utilise avec lui. Une chose est sur c'est que l'un des premiers souvenirs d'un café exceptionnel que nous avons pu boire est attaché à l'un de nos sens. Comme un coup de foudre. Ce n'était ni par l'odorat, ni par le goût, mais bien par le regard porté sur lui. Lui qui oscillait entre une aube écarlate et une aurore incandescente : une apparence Rouge Soleil.  Bonne écoute. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Bonjour à toutes et à tous, vous écoutez Rouge Soleil, une émission, un univers, un espace, qui va parler de la boisson la plus consommée au monde après l'eau :&nbsp;Le&nbsp;Café. L'idée à travers ce podcast est d'aborder sous tous les angles la plante qui permet d'obtenir cette boisson caféinée. Au-delà d'échanger sur la torréfaction, les extractions et autres points techniques, c'est également l'idée de s'attarder sur un mode de vie.&nbsp;Comme dit l'adage :&nbsp;dit moi ce que tu manges, je te dirai qui tu es.Et bien, c'est une posture identique que nous allons infiltrer dans le système rouge soleil.&nbsp;Oui, nous pensons qu'il y a mille et une chose à dire, à expliquer, à comprendre, à savoir, et à faire sur cette si petite chose qui généralement arrive en fin de repas :&nbsp;le café. Si vous êtes un simple amateur, barista en herbe, torréfacteur confirmé ou sincèrement curieux, rouge soleil va essayer de s'attaquer aux préjugés, aux a&nbsp;priori&nbsp;que la boisson que l'on nomme l'or noir porte avec elle. Si nous avons autant envie de parler et de défendre sa complexité, c'est que nous avons une relation passionnelle avec le café, pour ses teintes, ses nuances, ses arômes, ses odeurs, et sa capacité à ne pas dire la même chose suivant le langage qu'on utilise avec lui. Une chose est sur c'est que l'un des premiers souvenirs d'un café exceptionnel que nous avons pu boire est attaché à l'un de nos sens.&nbsp;Comme un coup de foudre.Ce n'était ni par l'odorat, ni par le goût, mais bien par le regard porté sur lui.&nbsp;Lui qui oscillait entre une aube écarlate et une aurore incandescente :&nbsp;une apparence Rouge Soleil.&nbsp; Bonne écoute. Hébergé par Acast. Visitez <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> pour plus d'informations.

Rouge Soleil

Уважаемые друзья, мы рады представить  подкаст - "Простая психология", где мы будем говорить о психологии простыми словами. 
Мы это - Валерий Ильин, Морозов Александр и Константин Филатов.
Каждую неделю будем обсуждать интересные и актуальные темы, связанные с психологией, эмоциями и человеческими отношениями.
Вместе с нами вы узнаете, как работает наша психика, как справляться со стрессом, как улучшить общение с родными и близкими.
В нашем подкасте вас ждут: • Приглашённые гости: эксперты в области психологии, коучи и интересные люди, которые поделятся своими знаниями и опытом.
• Мы будем обсуждать сложные темы в лёгкой и доступной форме, чтобы каждый мог понять и применить полученные знания в своей жизни.
Instagram* - запрещённая организация на территории Российской Федерации

Уважаемые друзья, мы рады представить подкаст - "Простая психология", где мы будем говорить о психологии простыми словами. Мы это - Валерий Ильин, Морозов Александр и Константин Филатов. Каждую неделю будем обсуждать интересные и актуальные темы, связанные с психологией, эмоциями и человеческими отношениями. Вместе с нами вы узнаете, как работает наша психика, как справляться со стрессом, как улучшить общение с родными и близкими. В нашем подкасте вас ждут:• Приглашённые гости: эксперты в области психологии, коучи и интересные люди, которые поделятся своими знаниями и опытом. • Мы будем обсуждать сложные темы в лёгкой и доступной форме, чтобы каждый мог понять и применить полученные знания в своей жизни. Instagram* - запрещённая организация на территории Российской Федерации

Уважаемые друзья, мы рады представить&nbsp; подкаст - "Простая психология", где мы будем говорить о психологии простыми словами.&nbsp;
Мы это - Валерий Ильин, Морозов Александр и Константин Филатов.
Каждую неделю будем обсуждать интересные и актуальные темы, связанные с психологией, эмоциями и человеческими отношениями.
Вместе с нами вы узнаете, как работает наша психика, как справляться со стрессом, как улучшить общение с родными и близкими.
В нашем подкасте вас ждут: • Приглашённые гости: эксперты в области психологии, коучи и интересные люди, которые поделятся своими знаниями и опытом.
• Мы будем обсуждать сложные темы в лёгкой и доступной форме, чтобы каждый мог понять и применить полученные знания в своей жизни.
Instagram* - запрещённая организация на территории Российской Федерации&nbsp;

Простая психология1

Chiara-Marie Hauser und Hannah Metzker haben 2019 zusammen mit dem Geschichtestudium an der Universität Wien angefangen. Eine von ihnen hat mittlerweile den Masterabschluss und schreibt an ihrer Doktorarbeit, die andere kann sich nach wie vor keine Jahreszahlen merken. Die beiden Historikerinnen werden durch den halben "Historian" in "Two and a half Historians" - Wikipedia - ergänzt. Jede Folge bringt eine von ihnen einen Wikipedia-Artikel mit, um das gewählte Thema tiefgründiger zu beleuchten. Von Serienmördern bis sowjetischen Panzern ist alles dabei!
Instagram: @TwoAndAHalfHistorians

Chiara-Marie Hauser und Hannah Metzker haben 2019 zusammen mit dem Geschichtestudium an der Universität Wien angefangen. Eine von ihnen hat mittlerweile den Masterabschluss und schreibt an ihrer Doktorarbeit, die andere kann sich nach wie vor keine Jahreszahlen merken. Die beiden Historikerinnen werden durch den halben "Historian" in "Two and a half Historians" - Wikipedia - ergänzt. Jede Folge bringt eine von ihnen einen Wikipedia-Artikel mit, um das gewählte Thema tiefgründiger zu beleuchten. Von Serienmördern bis sowjetischen Panzern ist alles dabei! Instagram: @TwoAndAHalfHistorians

Two and a Half Historians

Nous sommes Maxime et Camille, deux ophtalmos passionnés. En compagnie d'un invité, nous décryptons dans chaque épisode de ce podcast un sujet lié à l'ophtalmologie. Préparez-vous à y voir plus clair !


Ecriture : Maxime Delbarre  (https://ophtalmologue-montpellier.fr/)&amp; Camille Rambaud (https://chirurgie-cataracte.paris/)
Production : MedShake Studio (https://medshake-studio.com/) 
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

Nous sommes Maxime et Camille, deux ophtalmos passionnés. En compagnie d'un invité, nous décryptons dans chaque épisode de ce podcast un sujet lié à l'ophtalmologie. Préparez-vous à y voir plus clair ! Ecriture : Maxime Delbarre (https://ophtalmologue-montpellier.fr/)& Camille Rambaud (https://chirurgie-cataracte.paris/) Production : MedShake Studio (https://medshake-studio.com/) Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

Nous sommes Maxime et Camille, deux ophtalmos passionnés. En compagnie d'un invité, nous décryptons dans chaque épisode de ce podcast un sujet lié à l'ophtalmologie. Préparez-vous à y voir plus clair !


Ecriture : Maxime Delbarre  (https://ophtalmologue-montpellier.fr/)&amp; Camille Rambaud (https://chirurgie-cataracte.paris/)
Production : MedShake Studio (https://medshake-studio.com/)&nbsp;
Hébergé par Ausha. Visitez ausha.co/fr/politique-de-confidentialite pour plus d'informations.

OPHTALMOS

A podcast where we explore the science behind getting clean and sober, and why there may be a need for more inclusivity in the 12-step programs. Hosted by a certified addictions counselor who also has personal experience with addiction and recovery.Each episode will feature an interview with someone who is either in recovery or an expert in the field. We will explain how the classic 12-step recommendations can be understood in less scary terms. Also, we will discuss why certain therapeutic interventions are suggested and how they can be supported with research and evidence. There will be links to articles, studies, and research papers, making every claim easy to fact-check and read about.With so many spiritual and faith-based systems, we wanted to provide a safe space for people who are more evidence-minded or perhaps even have trauma from religion or spiritual abuse. We believe that recovery is possible for everyone, regardless of what you believe. And we can demonstrate that even the most stubborn, pedantic, agnostic, or atheist people can still find a way to achieve the self-reflection necessary for recovery.So join us and listen to some interesting stories from people all over the world battling their alcoholism and addiction one day at a time. Have fun clicking the links to make sure that we aren't just making it all up as we go. We invite any questions in the name of discussion, goodwill, and recovery. If you are like us, you will need evidence to believe anything we say, and that's perfectly ok. Whatever helps a person who suffers.Any questions, please email Max Ariel: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:iammaxariel@gmail.com">iammaxariel@gmail.com</a>Special thanks to the folks at Grammer for helping with the artwork and for helping us say what we wanted to say: <a target="_blank" rel="noopener noreferrer nofollow" href="https://grammercreative.com/">https://grammercreative.com/</a>

A podcast where we explore the science behind getting clean and sober, and why there may be a need for more inclusivity in the 12-step programs. Hosted by a certified addictions counselor who also has personal experience with addiction and recovery. Each episode will feature an interview with someone who is either in recovery or an expert in the field. We will explain how the classic 12-step recommendations can be understood in less scary terms. Also, we will discuss why certain therapeutic interventions are suggested and how they can be supported with research and evidence. There will be links to articles, studies, and research papers, making every claim easy to fact-check and read about. With so many spiritual and faith-based systems, we wanted to provide a safe space for people who are more evidence-minded or perhaps even have trauma from religion or spiritual abuse. We believe that recovery is possible for everyone, regardless of what you believe. And we can demonstrate that even the most stubborn, pedantic, agnostic, or atheist people can still find a way to achieve the self-reflection necessary for recovery. So join us and listen to some interesting stories from people all over the world battling their alcoholism and addiction one day at a time. Have fun clicking the links to make sure that we aren't just making it all up as we go. We invite any questions in the name of discussion, goodwill, and recovery. If you are like us, you will need evidence to believe anything we say, and that's perfectly ok. Whatever helps a person who suffers. Any questions, please email Max Ariel: iammaxariel@gmail.com Special thanks to the folks at Grammer for helping with the artwork and for helping us say what we wanted to say: https://grammercreative.com/

A podcast where we explore the science behind getting clean and sober, and why there may be a need for more inclusivity in the 12-step programs. Hosted by a certified addictions counselor who also has personal experience with addiction and recovery.Each episode will feature an interview with someone who is either in recovery or an expert in the field. We will explain how the classic 12-step recommendations can be understood in less scary terms. Also, we will discuss why certain therapeutic interventions are suggested and how they can be supported with research and evidence. There will be links to articles, studies, and research papers, making every claim easy to fact-check and read about.With so many spiritual and faith-based systems, we wanted to provide a safe space for people who are more evidence-minded or perhaps even have trauma from religion or spiritual abuse. We believe that recovery is possible for everyone, regardless of what you believe. And we can demonstrate that even the most stubborn, pedantic, agnostic, or atheist people can still find a way to achieve the self-reflection necessary for recovery.So join us and listen to some interesting stories from people all over the world battling their alcoholism and addiction one day at a time. Have fun clicking the links to make sure that we aren't just making it all up as we go. We invite any questions in the name of discussion, goodwill, and recovery. If you are like us, you will need evidence to believe anything we say, and that's perfectly ok. Whatever helps a person who suffers.Any questions, please email Max Ariel: <a href="mailto:iammaxariel@gmail.com" rel="noopener noreferrer">iammaxariel@gmail.com</a>Special thanks to the folks at Grammer for helping with the artwork and for helping us say what we wanted to say: <a href="https://grammercreative.com/" rel="noopener noreferrer">https://grammercreative.com/</a>

Evidence Based Recovery

This is your Bird Flu Intel: Facts, Not Fear, on H5N1 podcast. Bird Flu Intel: Facts, Not Fear on H5N1 is your go-to podcast for reliable and evidence-based information on the avian influenza virus. In a world where misinformation spreads rapidly, it’s vital to separate fact from fiction, and this podcast is dedicated to doing just that. Hosted by experts and structured to debunk myths surrounding H5N1, each episode features a concise, rational examination of common misconceptions about the virus. Through engaging dialogues between our [FACT CHECKER] and [SCIENTIST], you’ll gain clarity on myths such as the exaggerated spread of H5N1 to humans or misunderstanding its actual impact. Hear scientific evidence that dispels these myths, making the complex simple and accessible. Learn about the mechanisms of misinformation, how it can multiply fear, and the harm it causes. Equip yourself with powerful tools to evaluate the quality of information, ensuring you can discern credible sources from unreliable ones. Stay informed with the current scientific consensus on key aspects of H5N1 and explore areas where questions remain unanswered, providing a balanced view of what’s known and what’s still emerging. Regularly updated, Bird Flu Intel empowers you with the knowledge you need to stay informed, stay safe, and keep fear at bay. Tune in to replace anxiety with understanding, and transform uncertainty into informed awareness. For more info go to <a href="https://www.quietplease.ai" target="_blank" rel="noreferrer noopener">https://www.quietplease.ai</a> Or these great deals  and more <a href="https://amzn.to/4hSgB4r" target="_blank" rel="noreferrer noopener">https://amzn.to/4hSgB4r</a>

This is your Bird Flu Intel: Facts, Not Fear, on H5N1 podcast.Bird Flu Intel: Facts, Not Fear on H5N1 is your go-to podcast for reliable and evidence-based information on the avian influenza virus. In a world where misinformation spreads rapidly, it’s vital to separate fact from fiction, and this podcast is dedicated to doing just that. Hosted by experts and structured to debunk myths surrounding H5N1, each episode features a concise, rational examination of common misconceptions about the virus.Through engaging dialogues between our [FACT CHECKER] and [SCIENTIST], you’ll gain clarity on myths such as the exaggerated spread of H5N1 to humans or misunderstanding its actual impact. Hear scientific evidence that dispels these myths, making the complex simple and accessible. Learn about the mechanisms of misinformation, how it can multiply fear, and the harm it causes. Equip yourself with powerful tools to evaluate the quality of information, ensuring you can discern credible sources from unreliable ones.Stay informed with the current scientific consensus on key aspects of H5N1 and explore areas where questions remain unanswered, providing a balanced view of what’s known and what’s still emerging. Regularly updated, Bird Flu Intel empowers you with the knowledge you need to stay informed, stay safe, and keep fear at bay. Tune in to replace anxiety with understanding, and transform uncertainty into informed awareness.For more info go to https://www.quietplease.aiOr these great deals and more https://amzn.to/4hSgB4r

This is your Bird Flu Intel: Facts, Not Fear, on H5N1 podcast. Bird Flu Intel: Facts, Not Fear on H5N1 is your go-to podcast for reliable and evidence-based information on the avian influenza virus. In a world where misinformation spreads rapidly, it’s vital to separate fact from fiction, and this podcast is dedicated to doing just that. Hosted by experts and structured to debunk myths surrounding H5N1, each episode features a concise, rational examination of common misconceptions about the virus. Through engaging dialogues between our [FACT CHECKER] and [SCIENTIST], you’ll gain clarity on myths such as the exaggerated spread of H5N1 to humans or misunderstanding its actual impact. Hear scientific evidence that dispels these myths, making the complex simple and accessible. Learn about the mechanisms of misinformation, how it can multiply fear, and the harm it causes. Equip yourself with powerful tools to evaluate the quality of information, ensuring you can discern credible sources from unreliable ones. Stay informed with the current scientific consensus on key aspects of H5N1 and explore areas where questions remain unanswered, providing a balanced view of what’s known and what’s still emerging. Regularly updated, Bird Flu Intel empowers you with the knowledge you need to stay informed, stay safe, and keep fear at bay. Tune in to replace anxiety with understanding, and transform uncertainty into informed awareness. For more info go to <a href="https://www.quietplease.ai" rel="noopener noreferrer">https://www.quietplease.ai</a> Or these great deals&nbsp; and more <a href="https://amzn.to/4hSgB4r" rel="noopener noreferrer">https://amzn.to/4hSgB4r</a>

Bird Flu Intel: Facts, Not Fear, on H5N1

「愛と宇宙にひらくラジオ」にようこそ。この番組は、スピリベラジオ、スピリチュアルラジオを経て「愛と宇宙にひらくラジオ」として、再スタートした番組です。

少しの間立ち止まって、呼吸と共に自分自身に戻るラジオ。外の世界で様々な役割を担っていても、このラジオの間は、自分自身に戻って、あなたの魂の愛を感じてください。そして、日常生活の中で使っていけるスピリチュアルの知恵をシェアしていきますので、毎日の生活の中に取り入れていただけたら、嬉しいです。

https://listen.style/p/zkabegxj?m85cMMHb

このラジオのお届けはアイヴィンイクコです。
自己紹介はこちら！https://note.com/ikukoqigongdance/n/nff2a0249f2b2

この番組を聞いてのご意見・ご感想は、ハッシュタグ #ひらくラジオ でつぶやいていただくか、メールでお願いいたします。また、ラジオを聞いてのご相談や、氣功クラスについてのお問い合わせもメールでお願いいたします！

📧 myqbreathingmethod@gmail.com

「愛と宇宙にひらくラジオ」にようこそ。この番組は、スピリベラジオ、スピリチュアルラジオを経て「愛と宇宙にひらくラジオ」として、再スタートした番組です。 少しの間立ち止まって、呼吸と共に自分自身に戻るラジオ。外の世界で様々な役割を担っていても、このラジオの間は、自分自身に戻って、あなたの魂の愛を感じてください。そして、日常生活の中で使っていけるスピリチュアルの知恵をシェアしていきますので、毎日の生活の中に取り入れていただけたら、嬉しいです。 https://listen.style/p/zkabegxj?m85cMMHb このラジオのお届けはアイヴィンイクコです。 自己紹介はこちら！https://note.com/ikukoqigongdance/n/nff2a0249f2b2 この番組を聞いてのご意見・ご感想は、ハッシュタグ #ひらくラジオ でつぶやいていただくか、メールでお願いいたします。また、ラジオを聞いてのご相談や、氣功クラスについてのお問い合わせもメールでお願いいたします！ 📧 myqbreathingmethod@gmail.com

愛と宇宙にひらくラジオ〜スピリチュアル＆リベラルアーツ

The kickass science and technology radio show that delivers an irreverent look at the week in science and technology.

This Week in Science (TWIS)

The Peer Review is a podcast that uses humor, everyday language, and experiences to highlight what it is like to be an academic. We delve into institutional processes related to being a graduate student, doing research, and publishing...we even talk to faculty about their experiences. Everybody is included!

The Peer Review is a podcast that uses humor, everyday language, and experiences to highlight what it is like to be an academic. We delve into institutional processes related to being a graduate student, doing research, and publishing...we even talk to faculty about their experiences. Everybody is included!

The Peer Review

Il Centro Studi Medì promosse, vent’anni fa, una ricerca su un fenomeno che aveva creato tanto “panico morale” a Genova intorno alla presenza di gruppi di giovani di origine latinoamericana che si erano aggregati nelle cosiddette “bande”. Uno studio che cercò di comprendere il fenomeno e smontare alcune storture del discorso pubblico dell’epoca. Ne nacque un libro a cura di Luca Queirolo Palmas e Andrea Torre, “Il fantasma delle bande. Genova e i latinos”, dando vita a diversi percorsi di ricerca e mediazione dei conflitti che coinvolsero molte persone e continuarono anche negli anni successivi. Abbiamo ripreso i fili di quella prima ricerca, avviando due percorsi paralleli, cercando i contatti di quei giovani "di ieri", per capire come sono proseguiti i loro percorsi di vita e provando a comprendere come sono, invece, i vissuti delle nuove generazioni, oggi. Nel tessere insieme queste narrazioni abbiamo anche tentato di mostrare come si siano trasformati alcuni fenomeni, spaziando nel tempo e nella città, grazie alle molte voci incontrate. Un ringraziamento particolare a tutte le persone che hanno condiviso narrazioni e riflessioni. Un podcast a cura di Centro Studi Medì. Migrazioni nel Mediterraneo Immagine di copertina "Constelación" di Carlos Lalvay Estrada Voce narrante e lavoro di ricerca di Ottavia Salvador  in collaborazione con Maddalena Bartolini, Francesca Lagomarsino, Francesca Martini, Andrea Torre con il sostegno di Fondazione Compagnia di San Paolo

Il Centro Studi Medì promosse, vent’anni fa, una ricerca su un fenomeno che aveva creato tanto “panico morale” a Genova intorno alla presenza di gruppi di giovani di origine latinoamericana che si erano aggregati nelle cosiddette “bande”. Uno studio che cercò di comprendere il fenomeno e smontare alcune storture del discorso pubblico dell’epoca. Ne nacque un libro a cura di Luca Queirolo Palmas e Andrea Torre, “Il fantasma delle bande. Genova e i latinos”, dando vita a diversi percorsi di ricerca e mediazione dei conflitti che coinvolsero molte persone e continuarono anche negli anni successivi. Abbiamo ripreso i fili di quella prima ricerca, avviando due percorsi paralleli, cercando i contatti di quei giovani "di ieri", per capire come sono proseguiti i loro percorsi di vita e provando a comprendere come sono, invece, i vissuti delle nuove generazioni, oggi. Nel tessere insieme queste narrazioni abbiamo anche tentato di mostrare come si siano trasformati alcuni fenomeni, spaziando nel tempo e nella città, grazie alle molte voci incontrate.Un ringraziamento particolare a tutte le persone che hanno condiviso narrazioni e riflessioni.Un podcast a cura di Centro Studi Medì. Migrazioni nel MediterraneoImmagine di copertina "Constelación" di Carlos Lalvay EstradaVoce narrante e lavoro di ricerca di Ottavia Salvador in collaborazione con Maddalena Bartolini, Francesca Lagomarsino, Francesca Martini, Andrea Torrecon il sostegno di Fondazione Compagnia di San Paolo

Il Centro Studi Medì promosse, vent’anni fa, una ricerca su un fenomeno che aveva creato tanto “panico morale” a Genova intorno alla presenza di gruppi di giovani di origine latinoamericana che si erano aggregati nelle cosiddette “bande”. Uno studio che cercò di comprendere il fenomeno e smontare alcune storture del discorso pubblico dell’epoca. Ne nacque un libro a cura di Luca Queirolo Palmas e Andrea Torre, “Il fantasma delle bande. Genova e i latinos”, dando vita a diversi percorsi di ricerca e mediazione dei conflitti che coinvolsero molte persone e continuarono anche negli anni successivi. Abbiamo ripreso i fili di quella prima ricerca, avviando due percorsi paralleli, cercando i contatti di quei giovani "di ieri", per capire come sono proseguiti i loro percorsi di vita e provando a comprendere come sono, invece, i vissuti delle nuove generazioni, oggi. Nel tessere insieme queste narrazioni abbiamo anche tentato di mostrare come si siano trasformati alcuni fenomeni, spaziando nel tempo e nella città, grazie alle molte voci incontrate. Un ringraziamento particolare a tutte le persone che hanno condiviso narrazioni e riflessioni. Un podcast a cura di Centro Studi Medì. Migrazioni nel Mediterraneo Immagine di copertina "Constelación" di Carlos Lalvay Estrada Voce narrante e lavoro di ricerca di Ottavia Salvador&nbsp; in collaborazione con Maddalena Bartolini, Francesca Lagomarsino, Francesca Martini, Andrea Torre con il sostegno di Fondazione Compagnia di San Paolo

Le molte voci di Genova #latinoamericana

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

In the heart of a bustling research lab at Oxford University, Dr. Sarah Johnson peered intently into her microscope. For years, she and her team had been working tirelessly on a project that could change the lives of millions. Their goal? To create a vaccine that could finally put an end to one of humanity's oldest and deadliest foes: malaria. Sarah's journey had begun years earlier when, as a young medical student, she had volunteered in a rural clinic in Burkina Faso. There, she had witnessed firsthand the devastating impact of malaria, particularly on children. The image of a mother cradling her feverish child, helpless against the parasites ravaging the little one's body, had stayed with her ever since. "We're close," Sarah muttered to herself, adjusting the focus on her microscope. "I can feel it." And indeed, they were. After years of painstaking research, countless failures, and glimmers of hope, Sarah and her team had developed a vaccine they called R21/Matrix-M. It was a mouthful of a name, but it held the promise of saving countless lives. Meanwhile, in a small village in Ghana, Kwame sat outside his home, swatting at mosquitoes in the evening air. His young daughter, Ama, lay inside, her small body wracked with fever. Malaria had struck again, as it did every year when the rains came. Kwame had lost his eldest son to the disease three years ago. Now, as he listened to Ama's labored breathing, he prayed for a miracle. Little did he know that halfway across the world, that miracle was taking shape in the form of a tiny vial of vaccine. Back in Oxford, Sarah's team received the news they had been waiting for. The results from their latest clinical trial were in, and they were nothing short of remarkable. The R21/Matrix-M vaccine had shown an efficacy rate of up to 77% in young children who received a booster dose. "This is it!" Sarah exclaimed, her eyes shining with excitement as she shared the news with her team. "We've done it!" But what exactly had they done? How did this tiny vial of liquid manage to outsmart a parasite that had been outwitting humans for millennia? The secret lay in the vaccine's clever design. It targeted a specific protein found on the surface of the malaria parasite called the circumsporozoite protein, or CSP for short. Think of CSP as the parasite's coat – by teaching the body's immune system to recognize and attack this coat, the vaccine effectively stopped the parasite in its tracks before it could cause harm. But the R21/Matrix-M vaccine had another trick up its sleeve. It included a special ingredient called an adjuvant – Matrix-M. This adjuvant worked like a megaphone for the immune system, amplifying the body's response to the vaccine and making it more effective. As news of the vaccine's success spread, it reached the ears of world leaders and health organizations. In boardrooms and government offices, plans were set in motion to bring this life-saving vaccine to those who needed it most. Ghana, Nigeria, and Burkina Faso were chosen as the first countries to receive the vaccine. For people like Kwame and his daughter Ama, this news brought a glimmer of hope in their ongoing battle against malaria. The logistics of distributing the vaccine were daunting. It required a coordinated effort between local healthcare providers, governments, and international health organizations. But the potential impact was too significant to ignore. Dr. Amina Diallo, a public health official in Burkina Faso, stood before a group of local healthcare workers, explaining the importance of the new vaccine. "This is not just another medicine," she said, her voice filled with passion. "This is our chance to rewrite the story of malaria in our country. Each dose we administer is a step towards a healthier future for our children." The rollout began slowly but steadily. In clinics and hospitals across the selected countries, children lined up to receive their shots. Parents, who had lived in fear of malaria for generations, dared to hope that their children might grow up in a world where the disease was no longer a constant threat. For Kwame and Ama, the vaccine came just in time. As Ama recovered from her bout with malaria, Kwame took her to their local clinic to receive the R21/Matrix-M vaccine. "Will this stop her from getting sick again?" Kwame asked the nurse as she prepared the injection. The nurse smiled gently. "It's not a guarantee," she explained, "but it will give her a much better chance of staying healthy. And with each child we vaccinate, we make our whole community stronger against malaria." As the needle entered Ama's arm, Kwame felt a weight lift from his shoulders. For the first time in years, he allowed himself to imagine a future where he didn't have to fear the coming of the rains and the mosquitoes they brought. Back in Oxford, Sarah and her team were far from resting on their laurels. The success of the R21/Matrix-M vaccine had energized them, spurring them on to even greater endeavors. "We've made a huge step forward," Sarah told her team, "but our work is far from over. There are other strains of malaria out there, other stages in the parasite's lifecycle that we can target. We need to keep pushing, keep innovating." And push they did. In labs around the world, inspired by the success of R21/Matrix-M, researchers redoubled their efforts. They explored new approaches, studied different proteins on the parasite's surface, and looked for ways to make vaccines even more effective. The impact of the R21/Matrix-M vaccine was soon felt across the affected regions. Hospital wards that had once been filled to capacity with malaria patients began to see fewer severe cases. Children who might once have missed school due to recurring bouts of the disease were now able to attend classes regularly. Dr. Diallo, reviewing the latest health statistics for her region, could hardly believe her eyes. "The number of malaria cases has dropped by over 50% in just one year," she announced to her team. "This vaccine is not just saving lives; it's transforming our entire healthcare system." Indeed, as the burden of malaria began to lift, hospitals and clinics found they had more resources to dedicate to other pressing health issues. The ripple effects of the vaccine's success were felt throughout society, from increased productivity as fewer work days were lost to illness, to improved educational outcomes as children spent more time in school. But the fight against malaria was far from over. While the R21/Matrix-M vaccine was a powerful tool, it was not a silver bullet. Mosquito control programs, distribution of bed nets, and other preventive measures remained crucial in the ongoing battle against the disease. Moreover, the parasite that caused malaria was notorious for its ability to adapt and evolve. Scientists knew that they needed to stay one step ahead, continuing to refine and improve their vaccines to maintain their effectiveness. Five years after the initial rollout of the R21/Matrix-M vaccine, Kwame stood proudly at Ama's school graduation ceremony. His daughter, now a healthy teenager, had not suffered a single bout of malaria since receiving the vaccine as a child. As he watched Ama accept her diploma, Kwame's mind wandered back to that fearful night when he had sat outside his home, swatting at mosquitoes and praying for a miracle. The miracle had come, not in the form of divine intervention, but through the dedicated work of scientists like Sarah and her team, and the collaborative efforts of countless individuals around the world. In her lab in Oxford, Sarah Johnson looked at a photo on her desk. It showed her standing with a group of smiling children in Burkina Faso, taken during a recent visit to see the impact of the vaccine firsthand. She picked up the photo, a smile playing on her lips. "We've come so far," she murmured, "but there's still so much to do." And with that, she turned back to her microscope, ready to face the next challenge in the ongoing fight against malaria. For Sarah, Kwame, Ama, and millions of others around the world, the R21/Matrix-M vaccine had turned the tide in humanity's ancient battle against the tiny parasite. It was a reminder of what could be achieved when human ingenuity, scientific rigor, and global cooperation came together to tackle even the most formidable of foes. As the sun set over Oxford and rose over Ghana, the world slept a little easier, knowing that each new day brought them closer to a future free from the scourge of malaria. The mosquito's reign of terror was coming to an end, one vaccine dose at a time. The success of the R21/Matrix-M vaccine had far-reaching implications beyond just the realm of public health. It sparked a renewed interest in tropical disease research, attracting funding and talented scientists to a field that had long been underfunded and overlooked. Governments and philanthropic organizations, seeing the tangible results of their investments, increased their support for similar initiatives targeting other neglected diseases. In universities across the globe, a new generation of students, inspired by the breakthrough, chose to pursue careers in infectious disease research and global health. They saw in Sarah's work a model for how science could make a real, measurable difference in the lives of millions. The vaccine's success also had unexpected economic benefits. As malaria rates dropped, tourism to previously high-risk areas began to increase. Local economies that had long suffered under the shadow of the disease started to flourish. Farmers who had once lost precious workdays to illness found themselves more productive, contributing to improved food security in their regions. But perhaps the most profound impact was on the children. In villages and cities across Africa, a generation was growing up without the constant threat of malaria hanging over them. They attended school more regularly, played outside wit

Malaria Vaccine

Bienvenidos a Campo 360, el espacio donde conectamos el conocimiento con la ciencia y exploramos los temas más relevantes y desafiantes del mundo agropecuario. Donde desentrañamos los misterios de la tierra y el campo, sin filtros y con toda la verdad.

Bienvenidos a Campo 360, el espacio donde conectamos el conocimiento con la ciencia y exploramos los temas más relevantes y desafiantes del mundo agropecuario. Donde desentrañamos los misterios de la tierra y el campo, sin filtros y con toda la verdad.

Campo360

Welcome to ”The Rural American Surgeon,” a podcast series dedicated to providing insights, resources, and a community for the surgeons of rural America. Your host, Randy Lehman, is an established authority on the multifaceted aspects of rural surgery—from the unique professional benefits and challenges, rural surgical training paradigms, current reimbursement landscape, and how to create triple win opportunities for sustainable rural surgery in partnerships with hospitals and rural communities.

This podcast is designed for both rural general surgeons and rural surgical specialists who are seeking not just advice and guidance on practicing in rural areas, but also inspiration to foster valuable partnerships across our great land.

Each episode is a deep dive into topics such as mastery of rural surgery, the rural lifestyle, fighting professional isolation, building a system to ensure surgical services are offered at a high level, using scarce resources wisely, achieving personal financial freedom, accessing a wealth of outside surgical resources, and inspiration at a high level of why what we do is important.

Welcome to ”The Rural American Surgeon,” a podcast series dedicated to providing insights, resources, and a community for the surgeons of rural America. Your host, Randy Lehman, is an established authority on the multifaceted aspects of rural surgery—from the unique professional benefits and challenges, rural surgical training paradigms, current reimbursement landscape, and how to create triple win opportunities for sustainable rural surgery in partnerships with hospitals and rural communities. This podcast is designed for both rural general surgeons and rural surgical specialists who are seeking not just advice and guidance on practicing in rural areas, but also inspiration to foster valuable partnerships across our great land. Each episode is a deep dive into topics such as mastery of rural surgery, the rural lifestyle, fighting professional isolation, building a system to ensure surgical services are offered at a high level, using scarce resources wisely, achieving personal financial freedom, accessing a wealth of outside surgical resources, and inspiration at a high level of why what we do is important.

The Rural American Surgeon

JMPRO es una organización comunitaria sin fines de lucro que comparte noticias e información esenciales con nuestras comunidades rurales en el oeste de Carolina del Norte (WNC) y con sus socios comunitarios a través del periodismo comunitario. En nuestro pódcast, exploramos temas de salud locales que afectan a WNC y ofrecemos información que ayuda a guiar a los socios comunitarios para servir mejor a nuestras comunidades. Escúchanos y conoce otros medios comunitarios de JMPRO en jmprocommunitymedia.org, Facebook, Instagram y AshevilleFM.
Las opiniones expresadas en este podcast son responsabilidad de los anfitriones y sus invitados, y no reflejan necesariamente la postura de JMPRO Community Media ni de sus afiliados.
______________________________
JMPRO is a grassroots nonprofit that shares essential news and information with our rural communities in WNC &amp; their community partners by way of community journalism. In our podcast, we explore local health issues impacting Western North Carolina (WNC), and information to help guide community partners to better serve our communities. Take a listen and explore other JMPRO Community Media outlets @ jmprocommunitymedia.org, facebook, instagram, and AshevilleFM.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the views of JMPRO Community Media or its affiliates.
 Reporteros comunitarios / noticias / Asheville / salud y bienestar / políticas / huracán Helene / zonas rurales / oeste de Carolina del Norte / community reporters / news / Asheville / health &amp; wellbeing / policy / Hurricane Helene / rural / Western North Carolina

JMPRO es una organización comunitaria sin fines de lucro que comparte noticias e información esenciales con nuestras comunidades rurales en el oeste de Carolina del Norte (WNC) y con sus socios comunitarios a través del periodismo comunitario. En nuestro pódcast, exploramos temas de salud locales que afectan a WNC y ofrecemos información que ayuda a guiar a los socios comunitarios para servir mejor a nuestras comunidades. Escúchanos y conoce otros medios comunitarios de JMPRO en jmprocommunitymedia.org, Facebook, Instagram y AshevilleFM. Las opiniones expresadas en este podcast son responsabilidad de los anfitriones y sus invitados, y no reflejan necesariamente la postura de JMPRO Community Media ni de sus afiliados. ______________________________ JMPRO is a grassroots nonprofit that shares essential news and information with our rural communities in WNC & their community partners by way of community journalism. In our podcast, we explore local health issues impacting Western North Carolina (WNC), and information to help guide community partners to better serve our communities. Take a listen and explore other JMPRO Community Media outlets @ jmprocommunitymedia.org, facebook, instagram, and AshevilleFM. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the views of JMPRO Community Media or its affiliates. Reporteros comunitarios / noticias / Asheville / salud y bienestar / políticas / huracán Helene / zonas rurales / oeste de Carolina del Norte / community reporters / news / Asheville / health & wellbeing / policy / Hurricane Helene / rural / Western North Carolina

JMPRO es una organización comunitaria sin fines de lucro que comparte noticias e información esenciales con nuestras comunidades rurales en el oeste de Carolina del Norte (WNC) y con sus socios comunitarios a través del periodismo comunitario. En nuestro pódcast, exploramos temas de salud locales que afectan a WNC y ofrecemos información que ayuda a guiar a los socios comunitarios para servir mejor a nuestras comunidades. Escúchanos y conoce otros medios comunitarios de JMPRO en jmprocommunitymedia.org, Facebook, Instagram y AshevilleFM.
Las opiniones expresadas en este podcast son responsabilidad de los anfitriones y sus invitados, y no reflejan necesariamente la postura de JMPRO Community Media ni de sus afiliados.
______________________________
JMPRO is a grassroots nonprofit that shares essential news and information with our rural communities in WNC &amp; their community partners by way of community journalism. In our podcast, we explore local health issues impacting Western North Carolina (WNC), and information to help guide community partners to better serve our communities. Take a listen and explore other JMPRO Community Media outlets @ jmprocommunitymedia.org, facebook, instagram, and AshevilleFM.
The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the views of JMPRO Community Media or its affiliates.
 Reporteros comunitarios / noticias / Asheville / salud y bienestar / políticas / huracán Helene / zonas rurales / oeste de Carolina del Norte / community reporters / news / Asheville / health &amp; wellbeing / policy / Hurricane Helene / rural / Western North Carolina&nbsp;

JMPRO Community Media Podcast

Космонавт-испытатель, участник беспрецедентного проекта Роскосмоса и Первого канала «Вызов»Антон Шкаплеров беседует со своими гостями о тайнах космоса. Антон Шкаплеров: «Мой подкаст — это знакомство зрителей с необъятной темой космоса. Это разъяснение разных нюансов, связанных с подготовкой к полетам, к необычным ситуациям на космических кораблях, к происходящим сейчас новшествам, связанных с этой сферой. Моя задача сделать это интересно и без усложнений». Подкасты выходят в ночном эфире «Первого канала» в рамках проекта «Подкаст.Лаб». Посмотреть видеооверсию можно на сайте: https://www.1tv.ru/podcasts/kosmicheskie-istorii Все подкасты «Первого» можно прослушать тут: https://podcastlab.mave.digital А также в официальном сообществе проекта: https://vk.com/1tv.podcasts

Космонавт-испытатель, участник беспрецедентного проекта Роскосмоса и Первого канала «Вызов»Антон Шкаплеров беседует со своими гостями о тайнах космоса.Антон Шкаплеров: «Мой подкаст — это знакомство зрителей с необъятной темой космоса. Это разъяснение разных нюансов, связанных с подготовкой к полетам, к необычным ситуациям на космических кораблях, к происходящим сейчас новшествам, связанных с этой сферой. Моя задача сделать это интересно и без усложнений».Подкасты выходят в ночном эфире «Первого канала» в рамках проекта «Подкаст.Лаб».Посмотреть видеооверсию можно на сайте: https://www.1tv.ru/podcasts/kosmicheskie-istoriiВсе подкасты «Первого» можно прослушать тут: https://podcastlab.mave.digitalА также в официальном сообществе проекта: https://vk.com/1tv.podcasts

Космонавт-испытатель, участник беспрецедентного проекта Роскосмоса и Первого канала «Вызов»Антон Шкаплеров беседует со своими гостями о тайнах космоса. Антон Шкаплеров: «Мой подкаст — это знакомство зрителей с необъятной темой космоса. Это разъяснение разных нюансов, связанных с подготовкой к полетам, к необычным ситуациям на космических кораблях, к происходящим сейчас новшествам, связанных с этой сферой. Моя задача сделать это интересно и без усложнений». Подкасты выходят в ночном эфире «Первого канала» в рамках проекта «Подкаст.Лаб». Посмотреть видеооверсию можно на сайте: https://www.1tv.ru/podcasts/kosmicheskie-istorii Все подкасты «Первого» можно прослушать тут: https://podcastlab.mave.digital А также в официальном сообществе проекта: https://vk.com/1tv.podcasts

КОСМИЧЕСКИЕ ИСТОРИИ Подкаст.Лаб

Podcast Prawny to miejsce, w którym prawo stoi na pierwszym miejscu, a specjaliści z różnych dziedzin prawa mówią o tym, co kochają - czyli o prawie. Moje nagrania mają na celu popularyzować wiedzę o prawie oraz pokazać, że każdego dnia z nim obcujemy, często nie będąc tego świadomi. Podcast Prawny to przede wszystkim ludzie, ja jako twórca tworze jedynie miejsce, w którym prawo gra główną rolę.  Dołącz do grona patronów w serwisie PATRONITE link poniżej: https://linktr.ee/podcastprawny

Podcast Prawny to miejsce, w którym prawo stoi na pierwszym miejscu, a specjaliści z różnych dziedzin prawa mówią o tym, co kochają - czyli o prawie. Moje nagrania mają na celu popularyzować wiedzę o prawie oraz pokazać, że każdego dnia z nim obcujemy, często nie będąc tego świadomi. Podcast Prawny to przede wszystkim ludzie, ja jako twórca tworze jedynie miejsce, w którym prawo gra główną rolę. Dołącz do grona patronów w serwisie PATRONITE link poniżej: https://linktr.ee/podcastprawny

Podcast Prawny

Monthly podcast of a live call-in show, hosted by ornithologist Cliff Shackelford for Red River Radio.

The Red River Radio Bird Calls Podcast

Reportajes informativos y divulgativos de ecología y desarrollo rural con el periodista y productor de documentales Ricardo Gamaza. <a target="_blank" rel="noopener noreferrer nofollow" href="https://ecoperiodismo.es/ecoblog/">Ecoperiodismo</a> en estado puro.

Reportajes informativos y divulgativos de ecología y desarrollo rural con el periodista y productor de documentales Ricardo Gamaza. Ecoperiodismo en estado puro.

Reportajes informativos y divulgativos de ecología y desarrollo rural con el periodista y productor de documentales Ricardo Gamaza. <a href="https://ecoperiodismo.es/ecoblog/" rel="noopener noreferrer">Ecoperiodismo</a> en estado puro.

Ecoperiodismo

Here is my podcast for my Knowledge Dissemination!

Here is my podcast for my Knowledge Dissemination!

Matthew's Multiple Mindsets - Matthew Arsenault

Sacred Legions interview secular saints, a term coined by author Kurt Vonnegut for people performing decently in an indecent world. Hosted by Max Goller, we find out what inspired our guests in their saintly journey and ask them to contribute volunteer and self-care resources for our audience that they will be able to find on our website, sacredlegions.org. As Kurt said, ""No damn cat and no damn cradle...There is only one rule I know of babies—goddamn it, you've got to be kind!"

Sacred Legions: A Podcast for Secular Saints

Podcast series from the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow.

15 Minutes on Health Inequalities

PAN – PsychoAktivaNews ist der Podcast vom Nachtschatten Verlag, der dich regelmäßig mit spannenden News und Hintergründen aus der Welt der psychoaktiven Kultur versorgt. Ob Hanfpolitik, Ethnobotanik, psychedelische Wissenschaft oder subkulturelle Trends – PAN bringt dir die wichtigsten Entwicklungen und Stimmen aus der internationalen Szene direkt in dein Ohr. Informativ, aufklärend und immer am Puls der Zeit.

Science Podcasts / Page 425

Constant Innovation

2018 אודיסאה בחלל 2018 a Space Odyssey Podcast

Evidence Based Podcasts in Paediatric Surgery

AlterFútbol

Ordem Natural

UTS 4 Climate

Есть тема!

Medizin trifft Zahnmedizin

NATURELLEMENT VOTRE

Rouge Soleil

Простая психология1

Two and a Half Historians

OPHTALMOS

Evidence Based Recovery

Bird Flu Intel: Facts, Not Fear, on H5N1

愛と宇宙にひらくラジオ〜スピリチュアル＆リベラルアーツ

This Week in Science (TWIS)

The Peer Review

Le molte voci di Genova #latinoamericana

Malaria Vaccine

Campo360

The Rural American Surgeon

JMPRO Community Media Podcast

КОСМИЧЕСКИЕ ИСТОРИИ Подкаст.Лаб

Podcast Prawny

The Red River Radio Bird Calls Podcast

Ecoperiodismo

Matthew's Multiple Mindsets - Matthew Arsenault

Sacred Legions: A Podcast for Secular Saints

15 Minutes on Health Inequalities

PAN - PsychoAktivaNews

Hör mal, wer da forscht - Der Podcast der TH Köln

CluPad

Neutrino Whispers: Human Design Dialogues

The Brain Show

Beatty's Podcast

How to Talk About Health with Krista Lamb

Editors

Космическая Подкасточная

Biomedics Talk Ball

The Healthy Forests Podcast

توکا کست

The Global Possibility Network (GPN) Podcast

1. Guðmundur Eggertsson - faðir erfðafræðinnar á Íslandi

The Quest for Knowledge

Business & Psychology

Biología en Voz Alta

Earth in Focus

Sea You - The Maritime Podcast